CA-CEPTON-TECHNOLOGIES
2.3.2021 14:02:09 CET | Business Wire | Press release
A state-of-the art electronic tolling system that utilizes high-performance lidar sensors from Cepton and a cutting-edge vehicle identification solution from Red Fox ID is expected to be deployed on a major highway turnpike crossing multiple states in the United States, thereby promising fast, highly accurate, barrier-free, real-time tolling to enable smooth traffic flows. This marks the maturing of the deep partnership between Cepton and Red Fox ID in bringing innovative, automated tolling solutions to major customers across North America, EMEA and Asia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210302005524/en/
Based on an extended collaboration with leading lidar solution provider Cepton, Red Fox ID – a leading designer and developer of vehicle identification and classification solutions - has developed a multi-lane, free flow tolling system called Quantum , which is able to accurately detect, track and classify vehicles of any size or type at highway speeds. Quantum uses Cepton’s Micro Motion Technology (MMT® ) based Sora™-P60 or Sora™-P90 lidar sensors for high-resolution vehicle profiling, to enable integrators and road operators to achieve highly accurate customer billing in real time, with free flow, barrier-free tolling.
For tolls to be charged correctly based on vehicle class, traditional tolling systems often use tollbooths for manual processing or depend on vehicle speed reduction infrastructure to allow for time to capture vehicle information. That can cause congestion, increased emissions and frustration amongst customers. More advanced systems that aim to enable faster tolling, however, are often subject to significant errors, such as missed vehicles or wrong vehicle classification, due to known limitations of the sensors currently being used, such as cameras and weight-based ground sensors. Vehicle classification errors can have significant operating cost consequences for tolling operators while leakage leads to lower revenues. With tollways processing tens of millions of vehicles a year, the cumulative impact of inaccuracies and errors creates significant administrative costs, losses and customer dissatisfaction.
Red Fox ID’s Quantum solution addresses such challenges by adding an extra layer of accuracy to the tolling system by integrating Cepton’s unique lidar technology. A gantry-mounted system using Quantum is therefore able to accurately detect and track vehicles, even as they switch lanes. The lidar-enabled Quantum solution captures and extracts high quality information, such as vehicle velocity, size and class. All of that information is used as input to a separate billing system to compute and apply the appropriate tolling charge. Quantum can also direct camera-based systems on the gantry to capture a vehicle’s front and rear plates in the event that a transponder cannot be detected. Through these innovations, Quantum has demonstrated a vehicle detection accuracy in all traffic conditions of 99.96%, an axle classification accuracy in all traffic conditions of 99.9% and a vehicle length accuracy of +/-5%. This world-class performance is enabled by Cepton’s innovative Sora-P sensor family which has been tested and proven during extended trials, including in various weather and light conditions.
The recently released Sora-P90 lidar features an industry-leading 380 Hz frame rate to deliver 1140 line scans per second, providing high-fidelity profiling of vehicles passing at highway speeds . Powered by Cepton’s patented, rotation-free, frictionless and mirrorless MMT® , the Sora-P90 is rugged, reliable and scalable, making it ideally suited for automated tolling applications. In addition, with its 90° horizontal field of view, the lidar can be set up using one gantry instead of requiring two separate sensors and gantries, making overall deployment more cost effective for tolling system integrators.
With their unparalleled experienced in building innovative tolling solutions, and deep understanding of the industry trend away from ground loop-based tolling systems towards next-generation gantry-based overhead systems powered by advanced sensor technologies, Red Fox ID has been working with Cepton on multiple trials and proof of concept projects across the globe since 2019. This has allowed both partners to expand the application of advanced lidar intelligence for high accuracy tolling on highways and roadways in a growing list of countries, across North America, EMEA and Asia.
Steve Bird, CEO of Red Fox ID, said: “Our industry’s drive for overhead tolling solutions has failed to materialize in the mainstream due, primarily, to a lack of sensors capable of achieving the high levels of accuracy required for a modern tolling product. The technical innovations enabled by Cepton offers us new design options. Improvements in the resolution of the data, the ability to deal with the full range of weather-related conditions, and the development of a sensor with an in-service lifespan suitable for tolling make it possible, for the first time, for us to develop an accurate, overhead free flow system. Our partnership with Cepton will be a game-changer in revolutionizing the tolling market.”
Dr. Jun Pei, CEO of Cepton, added: “It is very clear that lidar’s uses extend far beyond just serving as the ‘eyes’ of autonomous vehicles. Our lidar technology has a huge part to play in making our transport infrastructure smarter, safer, greener and more efficient, as we can see here following Quantum’s highly successful real-world testing. The key to success for toll operators and providers is minimal error and maximum yield, and we are excited to be partnering with Red Fox ID to help our mutual customers achieve this goal with our market-leading lidar technology. We look forward to working with them to expand our partnership worldwide.”
About Cepton Technologies, Inc.
Cepton provides state-of-the-art, intelligent, lidar-based solutions for a range of markets such as automotive (ADAS/AV), smart cities , smart spaces and smart industrial applications. Cepton’s patented MMT®-based lidar technology enables reliable, scalable and cost-effective solutions that deliver long range, high resolution 3D perception for smart applications.
Founded in 2016 and led by industry veterans with over two decades of collective experience across a wide range of advanced lidar and imaging technologies, Cepton is focused on the mass market commercialization of high performance, high quality lidar solutions. Cepton is headquartered in San Jose, California, USA, with a presence in Germany, Canada, Japan and India, to serve a fast-growing global customer base. For more information, visit www.cepton.com and follow us on Twitter and LinkedIn .
About Red Fox ID Limited
Red Fox ID is a technology provider, primarily for the global tolling market and also for the broader ITS markets.
A company with over 3 decades of proven experience in the delivery of innovative, forward looking and industry leading solutions for the world of all weather, multi-lane, free-flow automatic vehicle detection and classification (AVDC). System integrators, toll authorities and road operators select Red Fox ID for their experience in advance sensor integration and expertise in road side tolling systems, from the software to the road side Red Fox ID has domain experts that ensure timely delivery of the industries most accurate AVDC system.
For more information visit www.redfoxid.co.uk or contact us at sales@redfoxid.co.uk or call +44 7866845819.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005524/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
